-

Fist Assist Devices, LLC Announces 510(k) Clearance for Focal Arm Massage and Increased Vein Circulation

LOS ALTOS HILLS, Calif.--(BUSINESS WIRE)--Fist Assist Devices, LLC, has received FDA 510(k) clearance for use of the Fist Assist FA-1 device in the United States as an arm massage and increased vein circulation device and has commenced marketing the Fist Assist FA-1 device for that indication for use.

“We are thrilled to receive FDA 510(k) clearance for the Fist Assist FA-1 device for focal arm massage and increased arm vein circulation. This is a huge milestone for our company as we can now expand our commercialization efforts into the United States, a market we have been waiting to enter since our global launch in early 2020,” said Tej Singh MD, MBA, Chief Executive Officer and Founder of Fist Assist Devices, LLC. “This is a very exciting time for Fist Assist. We have been working for many years to bring the benefits of using the Fist Assist FA-1 device for arm massage and vein circulation to patients and consumers in the United States. Our goal at Fist Assist is to temporarily increase arm vein circulation in the treated areas and relieve minor muscle aches and pains.”

About Fist Assist Devices, LLC

Fist Assist Devices is a privately held company from Silicon Valley, CA that has developed the Fist Assist technology over the past 30 years. The Fist Assist technology is patent protected and is focused on developing an intermittent, external wearable pneumatic compression for arm massage and increased vein circulation in the United States and increased forearm vein enhancement and AV fistula dilation/maturation in India, Canada, Europe, Australia, and New Zealand.

For further information, connect to www.fistassistdevices.com

Contacts

Tej Singh MD, M.B.A
CEO & Founder
Fist Assist Devices, LLC
fistassistdevices@gmail.com
(650) 444-2599

Fist Assist Devices, LLC


Release Versions

Contacts

Tej Singh MD, M.B.A
CEO & Founder
Fist Assist Devices, LLC
fistassistdevices@gmail.com
(650) 444-2599

Social Media Profiles
More News From Fist Assist Devices, LLC

Fist Assist Devices, LLC Announces Australian Distribution Deal and Sales Launch

LAS VEGAS--(BUSINESS WIRE)--Fist Assist Devices, LLC, announces a three-year affiliation with Regional Health Care Group to commercialize and launch sales of the Fist Assist Model FA-1 device in Australia and New Zealand. The Fist Assist Model FA-1 is a wearable, patent protected, intermittent compression device that has CE Mark clearance for use in those conditions where vein dilation is desired in patients that will require or already have undergone arteriovenous fistula placement for eventua...

Fist Assist Devices Receives FDA “Breakthrough Device” Designation for the World’s First Wearable Vein Dilation Device for ESRD Patients

LAS VEGAS--(BUSINESS WIRE)--Fist Assist Devices, LLC, an innovative medical device company focused on vein dilation to facilitate the Chronic Kidney Disease (CKD) patient’s journey through End-Stage Renal Disease (ESRD), announced today that it received “Breakthrough Device” designation from the U.S. Food and Drug Administration (FDA) for the Fist Assist Model FA-1 device. The FA-1 is the world’s first wearable device for pre-surgical vein dilation that promotes AV fistula creation in adult pat...

Fist Assist Devices, LLC Announces Release of the p-FACT Cohort Data

LOS ALTOS HILLS, Calif.--(BUSINESS WIRE)--Fist Assist Devices, LLC, announces that data associated with the p-FACT cohort, a data subset of the recently completed, non-significant risk Fist Assist Clinical Trial (FACT Trial) that focused on vein dilation in stage 4 patients with chronic renal failure, shows clear evidence that the Fist Assist device dilates the perforator vein. The p-FACT data derived from the FACT trial evaluated the use the FA-1 device developed by Fist Assist Devices, LLC, a...
Back to Newsroom